ASML Holding N.V. has unveiled a new €12 billion share repurchase authorization for 2026, marking a substantial increase following its strong 2025 performance. The program, approved by the board on February 3, represents nearly 2.3% of the company’s current market capitalization and is designed to reduce the share count and enhance per-share metrics. This initiative follows record equipment sales—up 18% year-on-year in the fourth quarter—and underscores ASML’s commitment to shareholder returns as it continues to lead the photolithography market.

A recent survey of thirty-three equity analysts reveals an average recommendation of “Moderate Buy” on ASML stock. Among these, two have issued sell ratings, six maintain hold ratings, twenty-one recommend buy and four rate the shares as strong buy. The one-year target price consensus stands at $1,475, implying upside potential of approximately 10% from current levels. Notable broker actions include Barclays upgrading ASML to overweight in late January, Evercore ISI reiterating outperform in October, and Cantor Fitzgerald reaffirming overweight in December.

ASML’s balance sheet reflects a market capitalization exceeding $520 billion, a price-to-earnings ratio near 52 and debt‐to‐equity of 0.14, highlighting conservative leverage. The company declared a quarterly dividend of $3.1771 per share—up 69% from the prior payout—equating to an annualized $12.71 and a yield of roughly 0.9%. With a payout ratio of 24.6%, ASML has signaled sustainable distributions while maintaining a current ratio of 1.26 and a quick ratio of 0.79. These figures, combined with a 12-month share price range between $578.51 and $1,493.47, illustrate both stability and growth prospects for investors.